Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice

ChEBI2011-06-07 更新2026-07-21 收录

靶向治疗

代谢性肾病

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-27954 数据链接链接失效反馈

官方服务：

资源简介：

Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice

创建时间：

2011-06-07

Development of molecular intervention strategies for B-cell lymphoma

B细胞淋巴瘤

靶向治疗

There are many genetic mutations involved in B-cell lymphomagenesis. These mutations contribute to the prognosis of B-cell lymphomas and can be used for and targeted for intervention. This review prov

DataCite Commons2021-03-30 更新90

Targeting a newly-identified RNA polymerase II-associated PHF5A-PHF14-KMT2A transcriptional subcomplex with a KMT2A-WDR5 inhibitor impairs the self-renewal, pluripotency and in vivo tumorigenicity of pancreatic cancer stem cells

腺癌干细胞

靶向治疗

Pancreatic cancer remains one of the most aggressive and lethal cancers in humans. It is undeniably known for its notorious resistance to conventional chemotherapeutics which are often associated with

NIAID Data Ecosystem70

NPM-ALK expression levels identify two distinct signatures in Anaplastic Large Cell Lymphoma of Childhood

淋巴瘤分型

靶向治疗

Anaplastic large-cell lymphoma (ALCL) makes up approximately 15% of paediatric non-Hodgkin's lymphomas of childhood. The vast majority of them is associated with the t(2;5)(p23;q35) translocation that

NIAID Data Ecosystem60

Systemic oxaliplatin or in intra-arterial chemotherapy combined with LV5FU2 +/- Irinotecan and targeted therapy in first-line treatment of metastatic colorectal cancer restricted to the liver

结肠直肠癌

靶向治疗

Primary objectives: Comparison of radiological and/or clinical progression free survival between the arm with intraarterial oxaliplatin administration (Arms A and C) and those with intravenous oxalipl

NIAID Data Ecosystem90

The evolution of MET and NRAS gene amplification as sequential acquired resistance mechanisms in a patient with EGFR mutation positive non-small cell lung cancer

化疗耐药机制

靶向治疗

EGFR mutant non-small cell lung cancer patients disease demonstrates remarkable responses to EGFR targeted therapy, but inevitably they succumb to acquired resistance, which can be complex and difficu

NIAID Data Ecosystem70

Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice

资源简介：

相关数据集